Synergistic growth inhibition by afatinib and trametinib in preclinical oral squamous cell carcinoma models / Yee Pei San
Oral squamous cell carcinoma (OSCC) remains a challenging disease to manage due to limited efficacious treatments, hence finding more effective treatment approaches remains a priority. Given that the aberrant activation of epidermal growth factor receptor family receptors (ERBB) is a common event...
| Auteur principal: | |
|---|---|
| Format: | Thèse |
| Publié: |
2019
|
| Sujets: |